Pharvaris BV (PHVS) — Strategic Asset Allocation Index
Pharvaris BV (PHVS) has a Strategic Asset Allocation Index of 0.3% as of September 2023. Strategic assets (PP&E of $495.96K plus long-term investments of $-) total $495.96K, measured against net assets of $153.13 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Pharvaris BV to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Pharvaris BV Strategic Asset Allocation Index (2019–2022)
This chart shows how Pharvaris BV's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of September 2023, the index stands at 0.3%, representing strategic assets of $495.96K against net assets of $153.13 Million USD. For live market cap and overall valuation, see Pharvaris BV (PHVS) total market value.
Annual Strategic Asset Allocation Index for Pharvaris BV (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Pharvaris BV from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See PHVS net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.4% | $626.44K | $626.44K | $- | $149.26 Million | ▲ +0.2 pp |
| 2021 | 0.2% | $351.35K | $351.35K | $- | $204.95 Million | ▲ +0.1 pp |
| 2020 | 0.1% | $48.50K | $48.50K | $- | $95.79 Million | ▼ 0.0 pp |
| 2019 | 0.1% | $12.93K | $12.93K | $- | $18.67 Million | — |